Acute kidney injury is being redefined as a collection of syndromes, each of which could be targeted by specific biomarkers.
Advancements and Projections in the Acute Kidney Injury Treatment Market: Insights, Trends, Opportunities, and Recent ...
The following is a summary of “Association between perioperative platelet distribution width changes and postoperative acute ...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions ...
The following is a summary of “Factors and machine learning models for predicting successful discontinuation of continuous ...
Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a ...
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury: Toronto Wednesday, November 13, 2024, 1 ...
On Tuesday, the court, presided over by Justice E. Jaiteh of the Banjul High Court admitted into evidence medical reports ...
A recent study published in Kidney Research and Clinical Practice has shed light on the impact of sacubitril-valsartan ...
SeaStar Medical (ICU) has begun shipping QUELIMMUNE to a third hospital customer. QUELIMMUNE is the Company’s Selective Cytopheretic ...
SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary solutions ...